Journal of Substance Abuse Treatment
Volume 37, Issue 4 , Pages 362-367 , December 2009

Scaling-up interim methadone maintenance: Treatment for 1,000 heroin-addicted individuals

  • Robert P. Schwartz, M.D.

      Affiliations

    • Social Research Center, Friends Research Institute, Baltimore, MD 21201, USA
    • Open Society Institute-Baltimore, Baltimore, MD 21201, USA
    • Corresponding Author InformationCorresponding author. 1040 Park Avenue, Suite 103, Baltimore, MD 21201, USA. Tel.: +1 410 837 3977x276; fax: +1 410 752 4218.
    • ,
  • Jerome H. Jaffe, M.D.

      Affiliations

    • Social Research Center, Friends Research Institute, Baltimore, MD 21201, USA
    • Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    • ,
  • Kevin E. O'Grady, Ph.D.

      Affiliations

    • Department of Psychology, University of Maryland College Park, College Park, MD 20742, USA
    • ,
  • Babita Das, M.S.

      Affiliations

    • American University, Washington, DC 20016, USA
    • ,
  • David A. Highfield, Ph.D.

      Affiliations

    • Social Research Center, Friends Research Institute, Baltimore, MD 21201, USA
    • ,
  • Monique E. Wilson, Dr. Ph.H.

      Affiliations

    • Social Research Center, Friends Research Institute, Baltimore, MD 21201, USA

Received 6 February 2009 ,Revised 1 April 2009 ,Accepted 3 April 2009.

References 

  1. Adamson SJ, Sellman D. The pattern of intravenous drug use and associated criminal activity in patients on a methadone treatment waiting list. Drug and Alcohol Review. 1998;17:159–166
  2. Calsyn D, Wells E, Saxon A, Jackson T, Wrede A, Stanton V, et al. Contingency management of urinalysis results and intensity of counseling services have an interactive impact on methadone maintenance treatment outcome. Journal on Addictive Diseases. 1994;13:47–63
  3. Des Jarlais DC, Paone D, Friedman SR, Peyser N, Newman RG. Regulating controversial programs for unpopular programs for unpopular people: Methadone maintenance and syringe exchange programs. America Journal of Public Health. 1995;85:1577–1584
  4. Dolan K, Shearer J, White B, Zhou J, Kaldor J, Wodak A. Four-year follow up of imprisoned male heroin users and methadone treatment: Mortality, re-incarceration and hepatitis C infection. Addiction. 2005;100:820–828
  5. Dole V. Interim methadone clinics: An undervalued approach. American Journal of Public Health. 1991;81:1111–1112
  6. Federal Register, title 21 (codified at 58 CFR 495 Part 291) 1993.
  7. Federal Register, title 21 (codified at 42 CFR Part 8) 2001.
  8. Fountain J, Strang J, Griffiths P, Powis B, Gossop M. Measuring met and unmet need of drug misusers: Integration of quantitative and qualitative data. European Addiction Research. 2000;6:97–103
  9. Gossop M, Marsden J, Stewart D, Lehmann P, Strang J. Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: Results from the National Treatment Outcome Research Study. British Journal of General Practice. 1999;49:31–34
  10. Hubbard, R. L. (1996, February) Findings from DATOS show clients receiving less drug abuse services. Connection, 4, 8.
  11. Johnson R, Chutaupe M, Strain E, Walsh S, Stitzer M, Bigelow G. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New England Journal of Medicine. 2000;343:1290–1297
  12. Johnson R, Jaffe J, Fudala P. A controlled trial of buprenorphine treatment for opioid dependence. Journal of the American Medical Association. 1992;67:2750–2755
  13. Kraft, M. K., Rothbard, A. B., Hadley, T. R., McLellan, A. T., Asch, D. A. (1997) Are supplementary services provided during methadone maintenance really cost-effective? American Journal of Psychiatry, 154, 9, 1214–1219.
  14. Lewis DC. Access to narcotic treatment programs and medical care: Prospects for the expansion of methadone maintenance treatment. Journal of Addictive Diseases. 1999;18:5–21
  15. McLellan A, Arndt I, Metzger D, Woody G, O'Brien C. The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association,. 1993;269:1953–1959
  16. McLellan AT, Weisner C. Achieving the public health potential of substance abuse treatment: Implications for patient referral, treatment “matching” and outcome evaluation. In:  Bickel W,  DeGrandpre R editor. Drug policy and human nature. Baltimore: Williams & Wilkins; 1996;p. 127–154
  17. Metzger D, Woody G, McLellan A, O'Brien C, Druley P, Navaline H, et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndrome. 1993;6:1049–1056
  18. Northrop Grumman Information Technology Health Solutions, Public Health Division. Opioid Treatment Program Accreditation Evaluation. Task Order Number 277-00-6507. Report Submitted to the Center for Substance Abuse Treatment May 31, 2006.
  19. Patch VD, Fisch A, Levine ME, McKenna GJ, Raynes AE. A mortality study of waiting list patients at the Boston City Hospital methadone maintenance clinic. Proceedings National Conference on Methadone Treatment. 1973;1:523–529
  20. Peterson JA, Schwartz RP, Mitchell SG, Reisinger HS, Kelly SM, O'Grady KE, et al. Why don't out-of-treatment individuals enter methadone treatment programmes?. International Journal on Drug Policy. 2008, September 19;(electronic publication ahead of print)
  21. Schwartz R, Highfield D, Jaffe J, Brady J, Butler C, Rouse C, et al. A randomized controlled trial of interim methadone maintenance. Archives of General Psychiatry. 2006;63:102–109
  22. Schwartz R, Highfield D, Jaffe J, Highfield D, Callaman J, O'Grady K. A randomized controlled trial of interim methadone maintenance: 10-month follow-up. Drug and Alcohol Dependence. 2007;86:30–36
  23. Strain E, Stitzer M, Liebson I, Bigelow G. Randomized controlled trial of moderate versus high dose methadone in treatment of opioid dependence. Journal of the American Medical Association. 1999;281:1000–1005
  24. Wenger LD, Rosenbaum M. Drug treatment on demand – not. Journal of Psychoactive Drugs. 1994;26:1–11
  25. Woody G, McLellan A, Luborsky L, O'Brien C. Psychotherapy in community methadone programs: A validation study. American Journal of Psychiatry. 1995;152:1302–1308
  26. Woody G, Muñoz A. Efficacy, individual effectiveness, and population effectiveness in substance abuse treatment. Current Psychiatry Reports. 2000;2:505–507
  27. Yancovitz S, Des Jarlais D, Peyser N, Drew E, Friedmann P, Trigg H, et al. A randomized trial of an interim methadone maintenance clinic. American Journal of Public Health. 1991;81:1185–1191

PII: S0740-5472(09)00041-5

doi: 10.1016/j.jsat.2009.04.002

Journal of Substance Abuse Treatment
Volume 37, Issue 4 , Pages 362-367 , December 2009

Article Tools